Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Alphamab Co Ltd (9966 HK)
Watchlist
144
Analysis
Health Care
•
China
Alphamab Oncology produces and sells drugs. The Company manufactures and sells tumor immunobiology macromolecular targeted drug and other products. Alphamab Oncology provides services worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
3D Medicines
•
22 Jun 2023 08:55
3D Medicines (1244.HK) - The Bubble Will Eventually Burst
3DMed's current stock price is clearly unreasonable. Its financial situation and the prospects of core product indicate that its survival issues...
Xinyao (Criss) Wang
Follow
638 Views
Share
bearish
•
Quantitative Analysis
•
11 Jun 2023 10:05
Hong Kong Connect Flows (Jun 9th): Tencent, China Mobile, CCB
We analyzed the Hong Kong Connect Scheme for last week and highlight flows for Tencent, China Mobile, and China Construction Bank.
Ke Yan, CFA, FRM
Follow
514 Views
Share
bullish
•
Quantitative Analysis
•
04 Jun 2023 10:20
Hong Kong Connect Flows (Jun 2nd): Meituan, China Construction Bank, Cnooc
We analyzed southbound Hong Kong connect flows in the past week and highlight flows for Meituan, China Construction Bank, Cnooc.
Ke Yan, CFA, FRM
Follow
566 Views
Share
bullish
•
Quantitative Analysis
•
28 May 2023 10:15
Hong Kong Connect Flows (May 25th): Tencent, China Mobile, Li Ning, China Construction Bank
We analyzed the Hong Kong Connect Scheme for last week and highlight flows for Tencent, China Mobile, Li Ning, China Construction Bank。
Ke Yan, CFA, FRM
Follow
705 Views
Share
bullish
•
Quantitative Analysis
•
21 May 2023 10:10
Hong Kong Connect Flows (May 19th): Tencent, China Construction Bank, China Mobile, Li Auto
We analyzed southbound Hong Kong connect flows in the past week and highlight flows for Tencent, China Construction Bank, China Mobile, Li Auto.
Ke Yan, CFA, FRM
Follow
767 Views
Share
First
Previous
12
13
14
15
16
17
18
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x